Authorization

Biotech IPO For The Week Ahead

(RTTNews) - The U.S. healthcare sector has witnessed 11 IPOs so far this month. Let's take a look at what's in store for the week ahead.

1. Oyster Point Pharma

Princeton, New Jersey-based Oyster Point Pharma is a clinical-stage biopharmaceutical company developing treatments for ocular surface diseases.

Founded in 2006, Oyster Point is scheduled to list its stock on the Nasdaq Global Select Market, under the symbol "OYST", on October 31, 2019.

The company has offered to sell 5.0 million ordinary shares with the initial public offering price expected to be between $16.00 and $18.00 per share. The underwriters have a 30-days option period to purchase up to 750,000 additional shares of common stock.
See also:
Leave a comment
News
  • Latest
  • Read
  • Commented
Calendar Content
«     2020    »
 12345
6789101112
13141516171819
20212223242526
2728293031